Literature DB >> 32205367

Phosphorylation Modulates the Coregulatory Protein Exchange of the Nuclear Receptor Pregnane X Receptor.

Wenqi Cui1, Xunan Shen1, Emre Agbas1, Brandon Tompkins1, Hadley Cameron-Carter1, Jeff L Staudinger2.   

Abstract

The pregnane X receptor (PXR), or nuclear receptor (NR) 1I2, is a ligand-activated NR superfamily member that is enriched in liver and intestine in mammals. Activation of PXR regulates the expression of genes encoding key proteins involved in drug metabolism, drug efflux, and drug transport. Recent mechanistic investigations reveal that post-translational modifications (PTMs), such as phosphorylation, play a critical role in modulating the bimodal function of PXR-mediated transrepression and transactivation of target gene transcription. Upon ligand binding, PXR undergoes a conformational change that promotes dissociation of histone deacetylase-containing multiprotein corepressor protein complexes while simultaneously favoring recruitment histone acetyl transferase-containing complexes. Here we describe a novel adenoviral vector used to deliver and recover recombinant human PXR protein from primary cultures of hepatocytes. Using liquid chromatography and tandem mass spectrometry we report here that PXR is phosphorylated at amino acid residues threonine 135 (T135) and serine 221 (S221). Biochemical analysis reveals that these two residues play an important regulatory role in the cycling of corepressor and coactivator multiprotein complexes. These data further our foundational knowledge regarding the specific role of PTMs, namely phosphorylation, in regulating the biology of PXR. Future efforts are focused on using the novel tools described here to identify additional PTMs and protein partners of PXR in primary cultures of hepatocytes, an important experimental model system. SIGNIFICANCE STATEMENT: Pregnane X receptor (PXR), or nuclear receptor 1I2, is a key master regulator of drug-inducible CYP gene expression in liver and intestine in mammals. The novel biochemical tools described in this study demonstrate for the first time that in cultures of primary hepatocytes, human PXR is phosphorylated at amino acid residues threonine 135 (T135) and serine 221 (S221). Moreover, phosphorylation of PXR promotes the transrepression of its prototypical target gene CYP3A4 through modulating its interactions with coregulatory proteins.
Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32205367      PMCID: PMC7228503          DOI: 10.1124/jpet.119.264762

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  76 in total

Review 1.  Nuclear receptor coregulators: cellular and molecular biology.

Authors:  N J McKenna; R B Lanz; B W O'Malley
Journal:  Endocr Rev       Date:  1999-06       Impact factor: 19.871

2.  The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux.

Authors:  T W Synold; I Dussault; B M Forman
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

3.  Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein).

Authors:  Laura M Hodges; Svetlana M Markova; Leslie W Chinn; Jason M Gow; Deanna L Kroetz; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-03       Impact factor: 2.089

Review 4.  Pregnane X receptor as a target for treatment of inflammatory bowel disorders.

Authors:  Jie Cheng; Yatrik M Shah; Frank J Gonzalez
Journal:  Trends Pharmacol Sci       Date:  2012-05-18       Impact factor: 14.819

5.  Insights from a three-dimensional model into ligand binding to constitutive active receptor.

Authors:  Li Xiao; Xiaoming Cui; Vincent Madison; Ronald E White; K-C Cheng
Journal:  Drug Metab Dispos       Date:  2002-09       Impact factor: 3.922

6.  2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin.

Authors:  Ryan E Watkins; Jodi M Maglich; Linda B Moore; G Bruce Wisely; Schroeder M Noble; Paula R Davis-Searles; Mill H Lambert; Steven A Kliewer; Matthew R Redinbo
Journal:  Biochemistry       Date:  2003-02-18       Impact factor: 3.162

7.  A SUMO-acetyl switch in PXR biology.

Authors:  Wenqi Cui; Mengxi Sun; Shupei Zhang; Xunan Shen; Nadezhda Galeva; Todd D Williams; Jeff L Staudinger
Journal:  Biochim Biophys Acta       Date:  2016-02-12

8.  Identification and characterization of phosphorylation sites within the pregnane X receptor protein.

Authors:  Ayesha Elias; Anthony A High; Ashutosh Mishra; Su Sien Ong; Jing Wu; Junmin Peng; Taosheng Chen
Journal:  Biochem Pharmacol       Date:  2013-10-30       Impact factor: 5.858

9.  Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor.

Authors:  Bryan Goodwin; Karine C Gauthier; Michihisa Umetani; Michael A Watson; Matthew I Lochansky; Jon L Collins; Eran Leitersdorf; David J Mangelsdorf; Steven A Kliewer; Joyce J Repa
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-30       Impact factor: 11.205

10.  Identification of three novel natural product compounds that activate PXR and CAR and inhibit inflammation.

Authors:  Suticha Kittayaruksakul; Wenchen Zhao; Meishu Xu; Songrong Ren; Jing Lu; Ju Wang; Michael Downes; Ronald M Evans; Raman Venkataramanan; Varanuj Chatsudthipong; Wen Xie
Journal:  Pharm Res       Date:  2013-07-30       Impact factor: 4.200

View more
  6 in total

Review 1.  Uncovering post-translational modification-associated protein-protein interactions.

Authors:  Shu Wang; Arianna O Osgood; Abhishek Chatterjee
Journal:  Curr Opin Struct Biol       Date:  2022-03-22       Impact factor: 7.786

Review 2.  The Nuclear Receptor PXR in Chronic Liver Disease.

Authors:  Katia Sayaf; Ilaria Zanotto; Francesco Paolo Russo; Daniela Gabbia; Sara De Martin
Journal:  Cells       Date:  2021-12-27       Impact factor: 6.600

Review 3.  Insights into the critical role of the PXR in preventing carcinogenesis and chemotherapeutic drug resistance.

Authors:  Xiaxia Niu; Ting Wu; Gege Li; Xinsheng Gu; Yanan Tian; Hongmei Cui
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

Review 4.  Regulation of PXR Function by Coactivator and Corepressor Proteins: Ligand Binding Is Just the Beginning.

Authors:  Juan Pablo Rigalli; Dirk Theile; Julie Nilles; Johanna Weiss
Journal:  Cells       Date:  2021-11-12       Impact factor: 6.600

Review 5.  The Interface between Cell Signaling Pathways and Pregnane X Receptor.

Authors:  Robert S Rogers; Annemarie Parker; Phill D Vainer; Elijah Elliott; Dakota Sudbeck; Kaushal Parimi; Venkata P Peddada; Parker G Howe; Nick D'Ambrosio; Gregory Ruddy; Kaitlin Stackable; Megan Carney; Lauren Martin; Thomas Osterholt; Jeff L Staudinger
Journal:  Cells       Date:  2021-11-22       Impact factor: 6.600

6.  Phosphorylation-Induced Ubiquitination and Degradation of PXR through CDK2-TRIM21 Axis.

Authors:  Mengyao Qin; Yu Xin; Yong Bian; Xuan Yang; Tao Xi; Jing Xiong
Journal:  Cells       Date:  2022-01-13       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.